1. The Role of Adipokines in Surgical Procedures Requiring Both Liver Regeneration and Vascular Occlusion
    Ana Álvarez-Mercado et al, 2018, International Journal of Molecular Sciences CrossRef
  2. The A3 adenosine receptor agonist, namodenoson, ameliorates non‑alcoholic steatohepatitis in mice
    Pnina Fishman et al, 2019, International Journal of Molecular Medicine CrossRef
  3. Addition of Berberine to Preservation Solution in an Animal Model of Ex Vivo Liver Transplant Preserves Mitochondrial Function and Bioenergetics from the Damage Induced by Ischemia/Reperfusion
    Rui Martins et al, 2018, International Journal of Molecular Sciences CrossRef
  4. 2‑Cl‑IB‑MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines
    Jana Kotulova et al, 2022, International Journal of Molecular Medicine CrossRef
  5. Pre-conditions for eliminating mitochondrial dysfunction and maintaining liver function after hepatic ischaemia reperfusion
    Chenxia Hu et al, 2017, Journal of Cellular and Molecular Medicine CrossRef
  6. Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities
    Ping Wang et al, 2020, JHEP Reports CrossRef
  7. Roquin-1 Regulates Macrophage Immune Response and Participates in Hepatic Ischemia–Reperfusion Injury
    Lei Zheng et al, 2020, The Journal of Immunology CrossRef
  8. Ectonucleotidases in Intestinal and Hepatic Inflammation
    Marta Vuerich et al, 2019, Frontiers in Immunology CrossRef
  9. Design and in vivo activity of A3 adenosine receptor agonist prodrugs
    R. Rama Suresh et al, 2020, Purinergic Signalling CrossRef
  10. A3Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy
    Kenneth A. Jacobson et al, 2018, Medicinal Research Reviews CrossRef
  11. Dysregulation of Adenosinergic Signaling in Systemic and Organ-Specific Autoimmunity
    Marta Vuerich et al, 2019, International Journal of Molecular Sciences CrossRef
  12. Mechanisms and therapeutic targets of ischemic acute kidney injury
    Sang Jun Han et al, 2019, Kidney Research and Clinical Practice CrossRef
  13. Effects of propofol combined with remifentanil anesthesia on the NO, endothelin and inflammatory cytokines in the plasma of patients with liver cirrhosis during the perioperative period
    Yongsheng Wang et al, 2019, Experimental and Therapeutic Medicine CrossRef
  14. Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies
    Ricardo O. S. Soares et al, 2019, International Journal of Molecular Sciences CrossRef
  15. Randomised clinical trial: A phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis
    Rifaat Safadi et al, 2021, Alimentary Pharmacology & Therapeutics CrossRef
  16. A Non-imaging High Throughput Approach to Chemical Library Screening at the Unmodified Adenosine-A3 Receptor in Living Cells
    Maria Augusta Arruda et al, 2017, Frontiers in Pharmacology CrossRef